Hospice News June 29, 2022
Jim Parker

Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care.

Several lawmakers expressed these reservations during a House Energy and Commerce Committee’s Oversight and Investigation subcommittee hearing that focused on the Medicare Advantage program.

“Improper claim denials and increased use of prior authorizations are preventing beneficiaries from receiving the care they need,” Energy and Commerce Chairman Frank Pallone, Jr. (D-N.J.) said during the hearing. “While there are many plans that appear to be acting responsibly, some are not, and these bad actors are costing taxpayers money and, more importantly, jeopardizing the health of seniors.”

Officials from several federal agencies testified, including the U.S. Department of Health & Human Services...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, OIG, Survey / Study, Trends
Medicare Advantage Growth Could Normalize, but Nursing Home Leaders Call for Rate Floor and Other Changes
Patient advocates shred Becerra's copay accumulator comments
How restrictive are Medicare Advantage provider networks?
Star Ratings and Member Experience: Two Sides of the Same Coin
New Compliance Obligations for PACE Organizations Coming in 2025

Share This Article